Cargando…

Acupoint nanocomposite hydrogel for simulation of acupuncture and targeted delivery of triptolide against rheumatoid arthritis

BACKGROUND: Attenuating inflammatory response and relieving pain are two therapeutic therapeutical goals for rheumatoid arthritis (RA). Anti-inflammatory and analgesic drugs are often associated with many adverse effects due to nonspecific distribution. New drug delivery systems with practical targe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Shujing, Liu, Heng, Wang, Xitong, Bi, Jiquan, Lu, Shengfeng, Zhu, Chenqi, Li, Huizhu, Kong, Wenliang, Chen, Rui, Chen, Zhipeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650546/
https://www.ncbi.nlm.nih.gov/pubmed/34876139
http://dx.doi.org/10.1186/s12951-021-01157-z
_version_ 1784611221404647424
author Ren, Shujing
Liu, Heng
Wang, Xitong
Bi, Jiquan
Lu, Shengfeng
Zhu, Chenqi
Li, Huizhu
Kong, Wenliang
Chen, Rui
Chen, Zhipeng
author_facet Ren, Shujing
Liu, Heng
Wang, Xitong
Bi, Jiquan
Lu, Shengfeng
Zhu, Chenqi
Li, Huizhu
Kong, Wenliang
Chen, Rui
Chen, Zhipeng
author_sort Ren, Shujing
collection PubMed
description BACKGROUND: Attenuating inflammatory response and relieving pain are two therapeutic therapeutical goals for rheumatoid arthritis (RA). Anti-inflammatory and analgesic drugs are often associated with many adverse effects due to nonspecific distribution. New drug delivery systems with practical targeting ability and other complementary strategies urgently need to be explored. To achieve this goal, an acupoint drug delivery system that can target deliver anti-inflammatory drugs and simulate acupuncture in relieving pain was constructed, which can co-deliver triptolide (TP) and 2-chloro-N (6)-cyclopentyl adenosine (CCPA). RESULTS: We have successfully demonstrated that acupoint nanocomposite hydrogel composed of TP-Human serum album nanoparticles (TP@HSA NPs) and CCPA could effectively treat RA. The result shows that CCPA-Gel can enhance analgesic effects specifically at the acupoint, while the mechanical and thermal pain threshold was 4.9 and 1.6 times compared with non-acupoint, respectively, and the nanocomposite gel further enhanced. Otherwise, the combination of acupoint and nanocomposite hydrogel exerted synergetic improvement of inflammation, bone erosion, and reduction of systemic toxicity. Furthermore, it could regulate inflammatory factors and restore the balance of Th17/Treg cells, which provided a novel and effective treatment strategy for RA. Interestingly, acupoint administration could improve the accumulation of the designed nanomedicine in arthritic paws (13.5% higher than those in non-acupoint at 48 h), which may explain the better therapeutic efficiency and low toxicity. CONCLUSION: This novel therapeutic approach-acupoint nanocomposite hydrogel, builds a bridge between acupuncture and drugs which sheds light on the combination of traditional and modern medicine. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-021-01157-z.
format Online
Article
Text
id pubmed-8650546
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86505462021-12-07 Acupoint nanocomposite hydrogel for simulation of acupuncture and targeted delivery of triptolide against rheumatoid arthritis Ren, Shujing Liu, Heng Wang, Xitong Bi, Jiquan Lu, Shengfeng Zhu, Chenqi Li, Huizhu Kong, Wenliang Chen, Rui Chen, Zhipeng J Nanobiotechnology Research BACKGROUND: Attenuating inflammatory response and relieving pain are two therapeutic therapeutical goals for rheumatoid arthritis (RA). Anti-inflammatory and analgesic drugs are often associated with many adverse effects due to nonspecific distribution. New drug delivery systems with practical targeting ability and other complementary strategies urgently need to be explored. To achieve this goal, an acupoint drug delivery system that can target deliver anti-inflammatory drugs and simulate acupuncture in relieving pain was constructed, which can co-deliver triptolide (TP) and 2-chloro-N (6)-cyclopentyl adenosine (CCPA). RESULTS: We have successfully demonstrated that acupoint nanocomposite hydrogel composed of TP-Human serum album nanoparticles (TP@HSA NPs) and CCPA could effectively treat RA. The result shows that CCPA-Gel can enhance analgesic effects specifically at the acupoint, while the mechanical and thermal pain threshold was 4.9 and 1.6 times compared with non-acupoint, respectively, and the nanocomposite gel further enhanced. Otherwise, the combination of acupoint and nanocomposite hydrogel exerted synergetic improvement of inflammation, bone erosion, and reduction of systemic toxicity. Furthermore, it could regulate inflammatory factors and restore the balance of Th17/Treg cells, which provided a novel and effective treatment strategy for RA. Interestingly, acupoint administration could improve the accumulation of the designed nanomedicine in arthritic paws (13.5% higher than those in non-acupoint at 48 h), which may explain the better therapeutic efficiency and low toxicity. CONCLUSION: This novel therapeutic approach-acupoint nanocomposite hydrogel, builds a bridge between acupuncture and drugs which sheds light on the combination of traditional and modern medicine. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-021-01157-z. BioMed Central 2021-12-07 /pmc/articles/PMC8650546/ /pubmed/34876139 http://dx.doi.org/10.1186/s12951-021-01157-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ren, Shujing
Liu, Heng
Wang, Xitong
Bi, Jiquan
Lu, Shengfeng
Zhu, Chenqi
Li, Huizhu
Kong, Wenliang
Chen, Rui
Chen, Zhipeng
Acupoint nanocomposite hydrogel for simulation of acupuncture and targeted delivery of triptolide against rheumatoid arthritis
title Acupoint nanocomposite hydrogel for simulation of acupuncture and targeted delivery of triptolide against rheumatoid arthritis
title_full Acupoint nanocomposite hydrogel for simulation of acupuncture and targeted delivery of triptolide against rheumatoid arthritis
title_fullStr Acupoint nanocomposite hydrogel for simulation of acupuncture and targeted delivery of triptolide against rheumatoid arthritis
title_full_unstemmed Acupoint nanocomposite hydrogel for simulation of acupuncture and targeted delivery of triptolide against rheumatoid arthritis
title_short Acupoint nanocomposite hydrogel for simulation of acupuncture and targeted delivery of triptolide against rheumatoid arthritis
title_sort acupoint nanocomposite hydrogel for simulation of acupuncture and targeted delivery of triptolide against rheumatoid arthritis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650546/
https://www.ncbi.nlm.nih.gov/pubmed/34876139
http://dx.doi.org/10.1186/s12951-021-01157-z
work_keys_str_mv AT renshujing acupointnanocompositehydrogelforsimulationofacupunctureandtargeteddeliveryoftriptolideagainstrheumatoidarthritis
AT liuheng acupointnanocompositehydrogelforsimulationofacupunctureandtargeteddeliveryoftriptolideagainstrheumatoidarthritis
AT wangxitong acupointnanocompositehydrogelforsimulationofacupunctureandtargeteddeliveryoftriptolideagainstrheumatoidarthritis
AT bijiquan acupointnanocompositehydrogelforsimulationofacupunctureandtargeteddeliveryoftriptolideagainstrheumatoidarthritis
AT lushengfeng acupointnanocompositehydrogelforsimulationofacupunctureandtargeteddeliveryoftriptolideagainstrheumatoidarthritis
AT zhuchenqi acupointnanocompositehydrogelforsimulationofacupunctureandtargeteddeliveryoftriptolideagainstrheumatoidarthritis
AT lihuizhu acupointnanocompositehydrogelforsimulationofacupunctureandtargeteddeliveryoftriptolideagainstrheumatoidarthritis
AT kongwenliang acupointnanocompositehydrogelforsimulationofacupunctureandtargeteddeliveryoftriptolideagainstrheumatoidarthritis
AT chenrui acupointnanocompositehydrogelforsimulationofacupunctureandtargeteddeliveryoftriptolideagainstrheumatoidarthritis
AT chenzhipeng acupointnanocompositehydrogelforsimulationofacupunctureandtargeteddeliveryoftriptolideagainstrheumatoidarthritis